Alkermes
ALKS
$24.44
Share price
1.22%
Change (1 day)
-19.80%
Change (1 year)
Categories
Alkermes (ALKS) Fails to deliver data
Key failure to deliver metrics for Alkermes:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $0.03 M
- Last 3 months FTD volume: $0.91 M
- Last year FTD volume: $30.46 M
Failures to deliver for Alkermes (ALKS) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Alkermes (ALKS) - since 2013
Volume in USD (price x number of shares), data since 2013Alkermes (ALKS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $1.56 M | -95.31% |
| 2023 | $33.36 M | 508.33% |
| 2022 | $5.48 M | -27.85% |
| 2021 | $7.6 M | 77.66% |
| 2020 | $4.27 M | -6.26% |
| 2019 | $4.56 M | -90.78% |
| 2018 | $49.5 M | 39.76% |
| 2017 | $35.42 M | 48.26% |
| 2016 | $23.89 M | -20.09% |
| 2015 | $29.89 M | 9.34% |
| 2014 | $27.34 M | 655.04% |
| 2013 | $3.62 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.13 B | $0.59 B | 🇺🇸 USA |
 Novartis NVS | $18.64 M | $83.53 M | 🇨🇭 Switzerland |
 Pfizer PFE | $10.32 M | $0.31 B | 🇺🇸 USA |
 Sanofi SNY | $21.22 M | $52.23 M | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | 🇺🇸 USA |
 AstraZeneca AZN | $88.62 M | $0.16 B | 🇬🇧 UK |
 Zogenix ZGNX | N/A | $54.53 M | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | N/A | $0.01 M | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $5.61 M | $30.31 M | 🇮🇱 Israel |